These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35898683)

  • 1. Outcome Prediction of Hematologic Malignancy in Critically Sick People.
    Velmurugan P; Moihanavel V; Altayar MA; Jalal MM; Kabrah SM; Qanash H; Almashjary MN; Alshehri OM; Kunwar VS
    Biomed Res Int; 2022; 2022():3234484. PubMed ID: 35898683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy.
    Cornish M; Butler MB; Green RS
    Can Respir J; 2016; 2016():9431385. PubMed ID: 27445571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ICU mortality in patients with hematological malignancies: a singlecenter, retrospective cohort study from Turkey.
    Bıkmaz ŞGA; Gökçe O; Haşimoğlu MM; Boyacı N; Türkoğlu M; Yeğin ZA; Özkurt ZN; Yağcı AM
    Turk J Med Sci; 2023 Feb; 53(1):340-351. PubMed ID: 36945922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
    Kalicińska E; Kuszczak B; Dębski J; Szukalski Ł; Wątek M; Strzała J; Rybka J; Czyż J; Lech-Marańda E; Zaucha J; Wróbel T
    Support Care Cancer; 2021 Jan; 29(1):323-330. PubMed ID: 32361829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in critically ill patients with hematological malignancy admitted to the general intensive care unit: a single-center experience in Japan.
    Irie H; Otake T; Kawai K; Hino M; Namazu A; Shinjo Y; Yamashita S
    J Anesth; 2017 Oct; 31(5):736-743. PubMed ID: 28766020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit.
    Pastores SM; Goldman DA; Shaz DJ; Kostelecky N; Daley RJ; Peterson TJ; Tan KS; Halpern NA
    Cancer; 2018 Jul; 124(14):3025-3036. PubMed ID: 29727916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of 6-month survival of critically ill patients with an active hematologic malignancy.
    Richards S; Wibrow B; Anstey M; Sidiqi H; Chee A; Ho KM
    J Crit Care; 2016 Dec; 36():252-258. PubMed ID: 27637467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
    Aygencel G; Boyacı Dündar N; Türkoğlu M; Yegin ZA; Özkurt ZN; Yağcı AM
    Turk J Med Sci; 2021 Aug; 51(4):2095-2100. PubMed ID: 33992040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit.
    Yeo CD; Kim JW; Kim SC; Kim YK; Kim KH; Kim HJ; Lee S; Rhee CK
    J Crit Care; 2012 Dec; 27(6):739.e1-6. PubMed ID: 23217573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.
    Bird GT; Farquhar-Smith P; Wigmore T; Potter M; Gruber PC
    Br J Anaesth; 2012 Mar; 108(3):452-9. PubMed ID: 22298243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and utility of scoring systems in patients with hematological malignancies admitted to the intensive care unit and required a mechanical ventilator.
    Nishida K; Palalay MP
    Hawaii Med J; 2008 Oct; 67(10):264-9. PubMed ID: 19097551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit.
    Ko H; Yan M; Gupta R; Kebbel K; Maiti A; Song J; Nates J; Overman MJ
    Oncologist; 2019 Apr; 24(4):483-490. PubMed ID: 30518614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic malignancies in the medical intensive care unit--Outcomes and prognostic factors.
    Grgić Medić M; Gornik I; Gašparović V
    Hematology; 2015 Jun; 20(5):247-53. PubMed ID: 25310461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical illness in patients with hematologic malignancy: a population-based cohort study.
    Ferreyro BL; Scales DC; Wunsch H; Cheung MC; Gupta V; Saskin R; Thyagu S; Munshi L
    Intensive Care Med; 2021 Oct; 47(10):1104-1114. PubMed ID: 34519845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcomes of patients with severe dengue admitted to intensive care units.
    Chen CM; Chan KS; Yu WL; Cheng KC; Chao HC; Yeh CY; Lai CC
    Medicine (Baltimore); 2016 Aug; 95(31):e4376. PubMed ID: 27495047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit.
    Al-Zubaidi N; Shehada E; Alshabani K; ZazaDitYafawi J; Kingah P; Soubani AO
    Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):206-218. PubMed ID: 29684341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of critically ill patients with hematological malignancies.
    Namendys-Silva SA; González-Herrera MO; García-Guillén FJ; Texcocano-Becerra J; Herrera-Gómez A
    Ann Hematol; 2013 May; 92(5):699-705. PubMed ID: 23328791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors and Outcomes in Critically Ill Patients with Hematological Malignancies Complicated by Hospital-Acquired Infections.
    Yerzhan A; Razbekova M; Merenkov Y; Khudaibergenova M; Abdildin Y; Sarria-Santamera A; Viderman D
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.